This conference will focus on international evidence-based guidelines on minimally invasive pancreas resection surgery (MIPR) that aim to give guidance to surgeons, hospital administrators, patients and medical societies on the outcome and direction to be taken regarding this challenging type of surgery. The conference will also aim to identify areas in which collaborative research is needed.
International experts in the field of pancreas surgery will gather to develop MIPR Guidelines based on literature review on PICO and non-PICO questions related to left sided pancreatectomy, central pancreatectomy, pancreatoduodenectomy, patient selection, techniques, training and implementation and instrumentation.
Horacio Asbun, M.D., FACS
Professor Mo Abu-Hilal
Professor Marc Besselink
Michael L. Kendrick, M.D.
Herbert J. Zeh, III, M.D.
Topics this Year
- Guidelines Development
- Learning Curve
- Patient Selection
- Central Pancreatectomy
- Minimally Invasive Pancreas Resection Surgery
- When to Convert
- Physicians who treat pancreatic diseases
- Institutional Guidelines Developers
- Fellowship Program Directors
- Minimally Invasive Surgeons
- Explain the current status of minimally invasive pancreas surgery (MIPR).
- Examine what the current evidence-based literature says about MIPR.
- Evaluate the advantages and disadvantages of MIPR
- Recognize the process of how the guidelines are created and the need for implementation.
- Identify current gaps in MIPR outcomes evidence and participate in initiatives to fill these gaps.
Accreditation and Credits
Baptist Health provides accredited continuing education (CME/CE) to doctors, nurses and allied health professionals.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
To CE Broker
This activity has been approved for 12 credit hours, CE Broker #20-689944, by the Florida Boards of Medicine, Osteopathic Medicine and the Florida Council of Physician Assistants.
This activity has been approved for 12 contact hours each by Florida State Board of Nursing, Baptist Health South Florida. CE Broker Provider #50-182.
Online registration will open soon.
Registration fee includes Continental Breakfast, Breaks and Lunch on Monday and Tuesday.
**Registration must be accompanied by a letter from the Fellowship/Residency Director.
Baptist Health has a process in place to ensure balance, independence, objectivity and scientific rigor in CME programming. Through this process Baptist Health identifies and, when applicable, resolves conflicts of interest of all individuals in a position to control or influence CME content, including faculty, conference directors, planners, content reviewers, CME Committee members and the CME Department staff. The CME Department is responsible for content review and, when necessary, makes modifications to resolve conflicts of interest so final presentations are fair and un-biased. These efforts are intended to affirm that the educational content is not controlled or influenced – directly or indirectly – by a commercial interest. As defined by ACCME, a commercial interest is any entity producing, marketing, re-selling, or distributing healthcare goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.
Individuals participating in this CME activity are responsible for identifying references to off-label or unapproved product usage in their discussions and recommendations.
Non-faculty Contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.
Baptist Health is not responsible for any image/illustration content prepared by faculty members for their presentations.
Disclosures for individuals in a position to control or influence content are provided below:
Christos Dervenis, M.D., has indicated that he has no relevant commercial relationships to disclose. Dr. Dervenis has disclosed that he will discuss off-label or unapproved usage.
Pier Giulianotti, M.D., has disclosed that he serves as a consultant to Covidien and is a proctor for Intuitive Surgical. Dr. Giulianotti has indicated that he will not discuss off-label or unapproved usage.
Melissa Hogg, M.D., has disclosed that she receives grant/research support from SAGES and Intuitive Surgical. Dr. Hogg has indicated that she will not discuss off-label or unapproved usage.
Rohan Jeyarajah, M.D., has disclosed that he serves as a consultant to Johnson & Johnson and Sirtex. Dr. Jeyarajah has indicated that he will not discuss off-label or unapproved usage.
Tobias Keck, M.D., has disclosed that he receives grant/research support from Olympus, and that he is a consultant to Intuitive Surgical, Medtronic and Olympus. Dr. Keck has also disclosed that he will discuss off-label or unapproved usage.
Norihiro Kokudo, M.D., has disclosed that he is a member of the speaker’s bureau for Eisai Pharmaceuticals. Dr. Kokudo has indicated that he will not discuss of off-label or unapproved usage.
John B. Martinie, M.D., has disclosed that he serves as a consultant to Intuitive Surgical and Medtronic Robotics, and that he is a member of the speaker’s Bureau for Ethicon Endosurgery. Dr. Martinie has indicated that he will not discuss off-label or unapproved usage.
Patrick Pessaux, M.D., Ph.D., has disclosed that he serves as a consultant to Integra. Dr. Pessaux has indicated that he will not discuss off-label or unapproved usage.
Herbert Zeh, M.D., has disclosed that he was a one-time moderator for Intuitive Surgical for a conference about robotic hepatobiliary surgery; Dr. Zeh received travel and lodging support only. Dr. Zeh has indicated that he will not discuss off-label or unapproved usage.
Maurice Zwart, MSc, has disclosed that he receives grant/research support from Intuitive Surgical. Dr. Zwart has indicated that he will not discuss off-label or unapproved usage.
Nothing to Disclose
The following committee members indicated that neither they nor their spouses/partners have relevant financial relationships with commercial interest companies, and they will not discuss off-label or unapproved usage in their review groups or presentations (if applicable):
Professor Mohd Abu-Hilal
Adnan Alseidi, M.D.
Alberto Balduzzi, M.D.
Claudio Bassi, M.D., FRCS, FACS
Professor Marc Besselink
Bergthor Bjornsson, M.D.
Ugo Boggi, M.D.
Mark P. Callery, M.D., FACS
Federica Cipriani, M.D.
Felipe J. Coimbra, M.D.
Kevin Conlon, M.A, Mch, FACS
Claudius Conrad, M.D.
Andrew Cook, MBBS
Alessandro Coppola, M.D.
Michael D’Angelica, M.D.
Marco Del Chiaro, M.D., Ph.D., FACS
Nicolas DeMartines, M.D.
Safi Dokmak, M.D., Ph.D.
Barish Edil, M.D.
Bjorn Edwin, M.D.
Ho-Seong Han, M.D., Ph.D.
Paul D. Hansen, M.D., FACS
Caitlin Hester, M.D.
Nicolas Jarufe, M.D.
Michael Kendrick, M.D.
Igor Khatkov, M.D., Ph.D.
Song Cheol Kim, M.D.
David Kooby, M.D.
Maarten Korrel, M.D.
Sanne Lof, M.D.
Marcel Machado, M.D.
Nipun Merchant, M.D.
Alma Moekotte, M.D
Quintus Molenaar, M.D., Ph.D.
Professor Masafami Nakumura
William H. Nealon, M.D.
Professor C. Palanivelu, MS, MCh, DNB
Henry Pitt, M.D.
Patricio M. Polanco, M.D.
Professor John Primrose
Arab Rawashdeh, M.D.
Dominic Sanford, M.D.
P. Senthilnathan, MS, DNB
Professor Shailesh V. Shrikhande
John A. Stauffer, M.D.
Kyoichi Takaori, M.D., Ph.D., FACS
Mark Talamonti, M.D.
Nicky Van Der Heijde, Ph.D. Student
Frederique Vissers, M.D.
Charles Vollmer, M.D.
Go Wakabayashi, M.D., Ph.D., FACS
R. Mathew Walsh, M.D.
Shin-E Wang, M.D.
Christopher L. Wolfgang, M.D., Ph.D.
Amer Zureikat, M.D.
All symposium activities (including educational sessions, meal functions, exhibit hall, etc.) are exclusively reserved for registered symposium attendees. Non-registered guests (including children, family members, colleagues, etc.) are not allowed in the symposium areas. Badges provided at registration are required for entrance into all functions and will be strictly enforced.
In consideration of the Americans with Disabilities Act, please contact us to determine your special service requirements.
Changes may occur that are beyond our control. In the unforeseen event the symposium is canceled, Baptist Health will refund attendees the entire amount of their registration fees. If you are traveling from outside of the area, we strongly suggest purchasing travel insurance.
Horacio Asbun, M.D., FACS
Chief, Hepatobiliary and Pancreas Surgery
Miami Cancer Institute
Professor Mohammed Abu Hilal, M.D., FRCS, FACS, EBSQ(HPB), Ph.D., DocEurp
Chair in Hepatobiliary Pancreatic and Minimally Invasive Surgery
Faculty of Medicine, Southampton University
Marc Besselink, M.D.
Professor, Department of Surgery
Amsterdam UMC, University of Amsterdam
Michael L. Kendrick, M.D.
Chair, Hepatobiliary and Pancreas Surgery, Department of Surgery
Herbert J. Zeh, III, M.D.
Professor and Chair Department of Surgery
University of Texas Southwestern Medical Center
Location and Accommodations
Eden Roc Hotel, Miami Beach Florida
4525 Collins Avenue Miami Beach, Florida 33140
Make your hotel reservation now by calling 855-433-3676 or going to Book your group rate for Baptist Health Event 2019 to receive the special group rate of $299, plus applicable taxes.
Hurry! Make your reservation today. The special group rate ends Saturday, February 23, 2019. Rates are based on availability.
NOTE: Partial credits are not available. Where credits are approved on a session-by-session basis, participants must attend each session in its entirety to receive complete credit for the session. (This does not apply to M.D.s and D.O.s.)
By attending our symposium, you consent to photography and videography of your image and likeness for use on Baptist Health websites, social media pages and press releases distributed for marketing purposes. Should you not agree to be photographed or recorded, you are responsible to notify us prior to this symposium.
Photography and recording of presenters and presentations are prohibited in the General Session, unless authorized by Baptist Health South Florida.
Baptist Health South Florida presents this CME activity for use by healthcare professionals for educational purposes only. Opinions, perspectives and information presented by the faculty represent their ideas and views, and participants should carefully consider all available scientific data before acting on knowledge gained through this activity. Additionally, participants should consult the US Food and Drug Administration (FDA) for approved uses prior to prescribing medications or utilizing medical devices discussed in this activity.
While Baptist Health makes reasonable efforts to ensure that accurate information is presented, no warranty, expressed or implied, is offered. Participants should rely on their own clinical judgment, knowledge and experience before applying information acquired to their professional use.